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Background
Axonal branching is a key principle for the establishment
of neuronal circuitry that allows an individual neuron to
innervate several target areas thus providing a physical
framework for parallel processing of information. Our pre-
vious search for molecular determinants of axonal branch-
ing unravelled a cGMP signalling pathway in embryonic
dorsal root ganglion (DRG) neurons composed of the
ligand C-type natriuretic peptide (CNP), the receptor
guanylyl cyclase B (GC-B, also termed Npr2), and the
cGMP-dependent protein kinase Ia (cGKIa) that is essen-
tial for the bifurcation of sensory axons at the dorsal root
entry zone of the spinal cord. Absence of any of these
components causes a complete loss of bifurcation where
sensory axons only turn in either a rostral or a caudal
direction (Figure 1A). Consequently mutant mice reveal a
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Figure 1 Scheme of branching errors observed in the absence of GC-B-mediated cGMP signalling in (A) DRG and (B) CSG neurons.
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reduced synaptic input onto second-order neurons in the
dorsal horn of the spinal cord.
Results
To examine whether the cGMP signalling system that
underlies axon bifurcation in DRG neurons may also
extend to other neuronal subpopulations we generated a
GC-B-lacZ reporter mouse line for a detailed analysis of
the GC-B expression pattern during embryonic develop-
ment. A strong expression of GC-B that correlated with
the localization of cGKIa was detected in neurons of all
cranial sensory ganglia (CSG) at early embryonic stages
when their central afferents enter the brainstem.
Furthermore, a complimentary distribution of the ligand
CNP at the entry zones of these axons in the hindbrain
was observed.
To analyze the impact of GC-B-mediated cGMP signal-
ling on axonal branching of CSG neurons we applied a
genetic strategy for sparse labelling of GC-B-expressing
neurons. For this purpose we generated a mouse mutant
(GC-B-CreERT2) encoding a tamoxifen-inducible variant
of Cre recombinase under control of the GC-B promoter
that in combination with a conditional alkaline phospha-
tase reporter (Z/AP) enables the visualization of individual
neurons within the genetically defined subset of GC-B-
expressing cells. Comparing the branching patterns of
GC-B heterozygous mice which resemble the wild-type
phenotype with those of homozygous GC-B-deficient ani-
mals we found that in the absence of GC-B the bifurcation
of axons of CSG neurons upon entering the hindbrain is
impaired and only an ascending or a descending arm is
formed (Figure 1B).
Conclusion
Our data demonstrate that neurons of CSG - similar to
DRG neurons - use GC-B-mediated cGMP signalling to
trigger axonal bifurcation.
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